Antidepressant Neurosteroids

We were excited to learn that our partners at Sage therapeutics have published trials of a formulation of the neurosteroid allopregnanolone for postpartum depression treatment.  Another neuroactive steroid completed Phase 2 trials for Major Depressive Disorder and was recently designated FDA Breakthrough Status.  This work seems to validate the studies we and others have done over the years characterizing […]